Endogenous Regulatory T Cells Promote M2 Macrophage Phenotype in Diabetic Stroke as Visualized by Optical Imaging

[1]  J. Aronowski,et al.  Excitatory pathway engaging glutamate, calcineurin, and NFAT upregulates IL-4 in ischemic neurons to polarize microglia , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  L. Wechsler,et al.  RNA sequencing reveals novel macrophage transcriptome favoring neurovascular plasticity after ischemic stroke , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Jun Chen,et al.  In Vivo Expansion of Regulatory T Cells with IL-2/IL-2 Antibody Complex Protects against Transient Ischemic Stroke , 2018, The Journal of Neuroscience.

[4]  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[5]  M. Chopp,et al.  Blood–Brain Barrier Disruption, Vascular Impairment, and Ischemia/Reperfusion Damage in Diabetic Stroke , 2017, Journal of the American Heart Association.

[6]  T. Shimohata,et al.  Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats , 2017, Scientific Reports.

[7]  M. Perez-Pinzon,et al.  Cerebral ischemic damage in diabetes: an inflammatory perspective , 2017, Journal of Neuroinflammation.

[8]  Á. Chamorro,et al.  Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation , 2016, The Lancet Neurology.

[9]  C. Kessler,et al.  Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients , 2016, Mediators of inflammation.

[10]  R. Franco,et al.  Alternatively activated microglia and macrophages in the central nervous system , 2015, Progress in Neurobiology.

[11]  S. Na,et al.  Amplification of Regulatory T Cells Using a CD28 Superagonist Reduces Brain Damage After Ischemic Stroke in Mice , 2015, Stroke.

[12]  H. Wiendl,et al.  CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  H. Ellingsgaard,et al.  Glycoprotein 130 Receptor Signaling Mediates α-Cell Dysfunction in a Rodent Model of Type 2 Diabetes , 2014, Diabetes.

[14]  Yuancheng Wang,et al.  Image-guided Pro-angiogenic Therapy in Diabetic Stroke Mouse Models Using a Multi-modal Nanoprobe , 2014, Theranostics.

[15]  Sunghee Cho,et al.  Deregulation of inflammatory response in the diabetic condition is associated with increased ischemic brain injury , 2014, Journal of Neuroinflammation.

[16]  K. Nadeau,et al.  Regulatory T cells and their roles in immune dysregulation and allergy , 2014, Immunologic research.

[17]  R. Leak,et al.  Adoptive Regulatory T-Cell Therapy Preserves Systemic Immune Homeostasis After Cerebral Ischemia , 2013, Stroke.

[18]  Wei Zhou,et al.  Boosting Regulatory T Cells Limits Neuroinflammation in Permanent Cortical Stroke , 2013, The Journal of Neuroscience.

[19]  F. Zhang,et al.  Adoptive regulatory T‐cell therapy protects against cerebral ischemia , 2013, Annals of neurology.

[20]  M. Chopp,et al.  The Neurorestorative Benefit of GW3965 Treatment of Stroke in Mice , 2013, Stroke.

[21]  R. Leak,et al.  Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia , 2012, Stroke.

[22]  A. Maisa,et al.  Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function , 2012, Aging cell.

[23]  H. Wiendl,et al.  Immune mechanisms of stroke. , 2012, Current opinion in neurology.

[24]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[25]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[26]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[27]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[28]  T. Hünig,et al.  Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease. , 2009, Blood.

[29]  C. Sommer,et al.  Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke , 2009, Nature Medicine.

[30]  P. De Baetselier,et al.  Experimental expansion of the regulatory T cell population increases resistance to African trypanosomiasis. , 2008, The Journal of infectious diseases.

[31]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[32]  S. John,et al.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages , 2007, Proceedings of the National Academy of Sciences.

[33]  B. McColl,et al.  Systemic Inflammatory Stimulus Potentiates the Acute Phase and CXC Chemokine Responses to Experimental Stroke and Exacerbates Brain Damage via Interleukin-1- and Neutrophil-Dependent Mechanisms , 2007, The Journal of Neuroscience.

[34]  C. Benjamin,et al.  Costimulation and Autoimmune Diabetes in BB Rats , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  R. Gold,et al.  Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis , 2005, The Journal of experimental medicine.

[36]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[37]  A. Tuttolomondo,et al.  Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. , 2003, Stroke.

[38]  R. Gold,et al.  Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies , 2003, Journal of Neuroimmunology.

[39]  P. Tso,et al.  Diabetes exacerbates inflammatory responses to ischemia-reperfusion. , 1996, Circulation.